A randomized crossover study of 40 patients with persistent PTH found that onabotulinum toxin-A decreased cumulative number of headaches/week by 43.3% in the treatment group and that the cumulative number of headaches/week increased by 35.1% among those in the placebo group [48]. The gene discussed is PTH; the disease is Headache.